Diabetic Retinopathy in Africa: Advantages of Screening

References

• . American Academy of Ophthalmology Retina Panel. Preferred practice pattern guidelines. Diabetic retinopathy. San Francisco, CA: American Academy of Ophthalmology; 2008. June 2010. http://www.aao.org/ppp. Accessed May 4, 2011
   Google Scholar
• . Sobngwi E, Mauvais-Jarvis F, Vexiau P, Mbanya JC, Gautier JF. Diabetes in Africans. Part 1: epidemiology and clinical specificities. Diabetes Metab (Paris). 2001;27(6):628–634
   PubMed Web of Science ®Google Scholar
• . Mbanya JC, Cruickshank JK, Forrester T,. Standardized comparison of glucose intolerance in west African-origin populations of rural and urban Cameroon, Jamaica, and Caribbean migrants to Britain. Diabetes Care. 1999;22(3):434–440
   PubMed Web of Science ®Google Scholar
• . Arfken CL, Reno PL, Santiago JV, Klein R. Development of proliferative diabetic retinopathy in African-Americans and whites with type 1 diabetes. Diab Care. 1998;21(5):792–795
   PubMed Web of Science ®Google Scholar
• . Aiello LM. Perspectives on diabetic retinopathy. Am J Ophthalmol. 2003;136(1):122–135
   PubMed Web of Science ®Google Scholar
• . Pai A, El Shafei M, Mohammed O, Al Hashimi M. Current concepts in intravitreal drug therapy for diabetic retinopathy. Saudi Journal of Ophthalmology. 2010;24:143–149
   PubMedGoogle Scholar
• . Stefansson E, Bek T, Porta M, Larsen N, Kristinsson JK, Agardh E. Screening and prevention of diabetic blindness. Acta Ophthalmol Scand. 2000;78(4):374–385
   PubMedGoogle Scholar
• . Lewallen S, Courtright P. Blindness in Africa: present situation and future needs. Br J Ophthalmol. 2001;85(8):897–903
   PubMed Web of Science ®Google Scholar
• . Read O, Cook C. Retinopathy in diabetic patients evaluated at a primary care clinic in Cape Town. SAMJ. 2007;97(10):941, 942, 944
   PubMed Web of Science ®Google Scholar
• . Levitt N. Diabetes in Africa. J Cardiovascular Risk. 2003;10:75–76
   Google Scholar
• . Mokdad AH, Ford ES, Bowman BA,. Prevalence of obesity, diabetes, and obesity-related health risk factors. JAMA. 2003;289(1):76–79
   PubMed Web of Science ®Google Scholar
• . Rotimi C, Daniel H, Zhou J,. Prevalence and determinants of diabetic retinopathy and cataracts in West African type 2 diabetes patients. Ethn Dis. 2003;13(2 suppl 2):S110–S117
   Google Scholar
• . Gebre-Yohannes A, Rahlenbeck SI. Glycemic control and its determinants in diabetic patients in Ethiopia. Diabetes Res Clin Pract. 1997;35(2–3):129–134
   PubMed Web of Science ®Google Scholar
• . Sobngwi E, Mbanya JC, Moukouri EN,. Microalbuminuria and retinopathy in a diabetic population of Cameroon. Diabetes Res Clin Pract. 1999;44(3):191–196
   PubMed Web of Science ®Google Scholar
• . Seyoum B, Mengitsu Z, Berhanu P,. Retinopathy in patients of Tikur Anbessa Hospital diabetic clinic. Ethiop Med J. 2001;39(2):123–131
   PubMedGoogle Scholar
• . Erasmus RT, Alanamu RA, Bojuwoye B,. Diabetic retinopathy in Nigerians: relation to duration of diabetes, type of treatment, and degree of control. East Afr Med J. 1989;66(4):248–254
   PubMed Web of Science ®Google Scholar
• . Kaimbo DK, Kabongo DK, Missotten L. Ocular complications in diabetes mellitus in Zaire. Bull Soc Belge Ophtalmol. 1995;255:107–113
   PubMedGoogle Scholar
• . Drabo PY, Kabore J, Lengani A. Complications of diabetes mellitus at the Hospital Center of Ouagadougou. Bull Soc Pathol Exot. 1996;89(3):191–195
   PubMed Web of Science ®Google Scholar
• . Lester FT. Clinical features, complications, and mortality in type 2 (non-insulin dependent) diabetic patients in Addis Ababa, Ethiopia. Ethiop Med J. 1993;31(2):109–126
   PubMedGoogle Scholar
• . Mbanya JC, Sobngwi E. Diabetes microvascular and macrovascular disease in Africa. J Cardiovasc Risk. 2003;10(2):97–102
   PubMedGoogle Scholar
• . Rahlenbeck SI, Gebre-Yohannes A. Prevalence and epidemiology of micro- and macroalbuminuria in Ethiopian diabetic patients. J Diabet Complic. 1997;11(6):343–349
   PubMed Web of Science ®Google Scholar
• . Beran D, Yudkin JS. Diabetes care in sub-Saharan Africa. Lancet. 2006;368(9548):1689–1695
   PubMed Web of Science ®Google Scholar
• . Gill G, Gebrekidan A, English P, Wile D, Tesfaye S. Diabetic complications and glycaemic control in remote North Africa. Q J Med. 2008;101(10):793–798
   Google Scholar
• . Dagogo-Jack S. Primary prevention of type-2 diabetes in developing countries. J Natl Med Assoc. 2006;98(3):415–519
   PubMed Web of Science ®Google Scholar
• . Onakpoya OH, Adeoye AO, Kolawole BA. Determinants of previous dilated eye examination among type II diabetics in Southwestern Nigeria. Eur J Intern Med. 2010;21:176–179
   PubMed Web of Science ®Google Scholar
• . The Diabetes Control and Complications Trial Research Group. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the Diabetes Control and Complications Trial. Diabetes. 1995;44(8):968–983
   PubMed Web of Science ®Google Scholar
• . White NH, Sun W, Cleary PA,. Prolonged effect of intensive therapy on the risk of retinopathy complications in patients with type 1 diabetes mellitus: 10 years after the Diabetes Control and Complications Trial. Arch Ophthalmol. 2008;126(12):1707–1715
   PubMed Web of Science ®Google Scholar
• . UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837–853
   PubMed Web of Science ®Google Scholar
• . Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ. 1998;317(7160):703–713
   PubMed Web of Science ®Google Scholar
• . Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group. Arch Ophthalmol. 1985;103(12):1796–1806
   PubMedGoogle Scholar
• . Javitt JC, Canner JK, Sommer A. Cost effectiveness of current approaches to the control of retinopathy in type I diabetics. Ophthalmology. 1989;96(2):255–164
   PubMed Web of Science ®Google Scholar
• . Javitt JC, Aiello LP. Cost-effectiveness of detecting and treating diabetic retinopathy. Ann Intern Med. 1996;124(1 pt 2):164–169
   PubMed Web of Science ®Google Scholar
• . Sharma S, Brown GC, Brown MM, Hollands H, Shah GK. The cost-effectiveness of grid laser photocoagulation for the treatment of diabetic macular edema: results of a patient-based cost-utility analysis. Curr Opin Ophthalmol. 2000;11:175–179
   PubMedGoogle Scholar
• . Gray A, Raikou M, McGuire A,. Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: economic analysis alongside randomised controlled trial (UKPDS 41). United Kingdom Prospective Diabetes Study Group. BMJ. 2000;320(7246):1373–1378
   PubMedGoogle Scholar
• . Standards of Medical Care in Diabetes 2009. Diabetes Care. 2010;33 ( suppl 1):S11
   PubMed Web of Science ®Google Scholar
• . Peters AL, Legoretta AP, Ossario RC, Davidson MB. Quality of outpatient care provided to diabetic patients: a health maintenance organization experience. Diabetes Care. 1996;19(6):601–606
   PubMed Web of Science ®Google Scholar
• . Stern E, Benbassat CA, Goldfracht M. Impact of a two-arm educational program for improving diabetes care in primary care centres. Int J Clin Pract. 2005;59(10):1126–1130
   PubMed Web of Science ®Google Scholar
• . Mash B, Powell D, du Plessis F, van Vuuren U, Michalowska M, Levitt N. Screening for diabetic retinopathy in primary care with a mobile fundal camera—evaluation of a South African pilot project. S Afr Med J. 2007;97(12):1284–1288
   PubMed Web of Science ®Google Scholar
• . Carmichael TR, Carp GI, Welsh ND, Kalk WJ. Effective and accurate screening for diabetic retinopathy using a 60° mydriatic fundus camera. S Afr Med J. 2005;95(1):57–61
   PubMed Web of Science ®Google Scholar
• . Grading diabetic retinopathy from stereoscopic color fundus photographs—an extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology. 1991;98( 5 suppl):786–806
   PubMed Web of Science ®Google Scholar
• . Williams GA, Scott IU, Haller JA, Maguire AM, Marcus D, McDonald R. Single-field fundus photography for diabetic retinopathy screening. Ophthalmology. 2004;111(5):1055–1062
   PubMed Web of Science ®Google Scholar
• . Massin P, Erginay A, Ben Mehidi A,. Evaluation of a new non-mydriatic digital camera for detection of diabetic retinopathy. Diabet Med. 2003;20(8):635–641
   PubMed Web of Science ®Google Scholar
• . Massin P, Aubert JP, Eschwege E,. Evaluation of a screening program for diabetic retinopathy in a primary care setting Dodia (Dépistage ophtalmologique du diabète) study. Diabetes Metab. 2005;31(2):153–162
   PubMed Web of Science ®Google Scholar
• . Baeza M, Orozco-Beltran D, Gil-Guillen VF,. Screening for sight threatening diabetic retinopathy using non-mydriatic retinal camera in a primary care setting: to dilate or not to dilate? Int J Clin Pract. 2009;63(3):433–428
   PubMed Web of Science ®Google Scholar
• . Harding S, Garvican L, Talbot J. The impact of national diabetic retinopathy screening on ophthalmology: the need for urgent planning. Eye. 2005;19(9):1009–1011
   PubMed Web of Science ®Google Scholar
• . Leese GP, Ahmed S, Newton RW,. Use of mobile screening unit for diabetic retinopathy in rural and urban areas. BMJ. 1993;306(6871):187–189
   PubMedGoogle Scholar
• . Sculpher M, Buxton M, Fergusson B, Humphreys J, Altman J, Spiegelhalter D. A relative cost effectiveness analysis of different methods of screening for diabetic retinopathy. Diabetic Med. 1991;8(7):644–650
   PubMed Web of Science ®Google Scholar
• . Luzio S, Hatcher S, Zahlmann G,. Feasibility of using the TOSCA telescreening procedures for diabetic retinopathy. Diabetic Medicine. 2004;21(10):1121–1128
   PubMed Web of Science ®Google Scholar